Patient Preference and Adherence
Volume 17, 2023 - Issue
Open access
286
Views
1
CrossRef citations to date
0
Altmetric
REVIEW
Long-Term Safety, Efficacy, and Patient-Centered Outcomes of Filgotinib in the Treatment of Rheumatoid Arthritis: Current Perspectives
Yoshiya Tanaka1 The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health Japan, Kitakyushu, JapanCorrespondence[email protected]
https://orcid.org/0000-0002-0807-7139View further author information
, https://orcid.org/0000-0002-0807-7139View further author information
Mark C Genovese2 Division of Immunology and Rheumatology, Stanford University, Stanford, CA, USA;3 Gilead Sciences, Inc, Foster City, CA, USAhttps://orcid.org/0000-0001-5294-4503View further author information
& Hironori Matsushima4 Gilead Sciences, Inc, Tokyo, JapanView further author information
Pages 2499-2516
|
Received 21 Apr 2023, Accepted 01 Aug 2023, Published online: 06 Oct 2023
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.